|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Departments of 1 Internal Medicine and 3 Anatomy, The Catholic University of Korea, Seoul, Korea 137-701; 2 Nephrology and Dialysis Unit, Department of Internal Medicine, Affiliated Hospital, YanBian University Medical College, 133000 YanJi, JiLin, China; and 4 Cellular Transplantation Division, Legacy Good Samaritan Hospital, Portland, Oregon 97210
Renal interstitial inflammation is an important factor in the pathogenesis of chronic cyclosporin A (CsA) nephropathy. We studied the expression of the chemoattractant osteopontin (OPN) and the relationship between OPN expression and tubulointerstitial injury in a rat model of chronic CsA nephropathy. Chronic CsA nephropathy was induced in Sprague-Dawley rats by administering CsA (15 mg/kg sc) for 5 wk and then withdrawing it for 5 or 10 wk. Renal function, histopathology (arteriolopathy, ED-1-positive cells, and tubulointerstitial fibrosis), renin-angiotensin system (RAS) activity, and OPN expression were observed during the follow-up period. Renal function deteriorated in CsA-treated rats, with the development of typical histopathology and activation of RAS. After CsA withdrawal, these parameters were significantly reversed (all P < 0.05). The upregulation of OPN mRNA and protein expression seen in CsA-treated rat kidneys was decreased 5 wk after CsA withdrawal and was further decreased after 10 wk. Of note, OPN mRNA expression correlated with the number of infiltrating macrophage (r = 0.651, P < 0.01) and tubulointerstitial fibrosis (r = 0.729, P < 0.01). These findings suggest that OPN expression and macrophage infiltration decrease after long-term CsA withdrawal in rats with established chronic CsA nephropathy, and this is closely associated with recovery from renal injury.
cyclosporin withdrawal; osteopontin; macrophage; tubulointerstitial fibrosis; renin-angiotensin system
This article has been cited by other articles:
![]() |
I. Tostivint, S. T. du Montcel, M. C. Jaudon, A. Mallet, P. Le Hoang, B. Bodaghi, G. Deray, and C. I. Bagnis Renal outcome after ciclosporin-induced nephrotoxicity Nephrol. Dial. Transplant., March 1, 2007; 22(3): 880 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Lim, C. Li, B.-K. Sun, K.-H. Han, W.-Y. Kim, Y.-W. Oh, J.-U. Lee, P. F. Kador, M. A. Knepper, J. M. Sands, et al. Long-term treatment with cyclosporine decreases aquaporins and urea transporters in the rat kidney Am J Physiol Renal Physiol, July 1, 2004; 287(1): F139 - F151. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, C. W. Yang, J. H. Park, S. W. Lim, B. K. Sun, J. Y. Jung, S. B. Kim, Y. S. Kim, J. Kim, and B. K. Bang Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy Am J Physiol Renal Physiol, January 1, 2004; 286(1): F46 - F57. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |